| blood vessel morphogenesis | GO:0048514 | 285 | 0.147 | |
| muscle contraction | GO:0006936 | 101 | 0.130 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.124 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.116 | |
| neutrophil mediated killing of gram positive bacterium | GO:0070946 | 2 | 0.106 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.103 | |
| protein secretion | GO:0009306 | 111 | 0.099 | |
| regulation of system process | GO:0044057 | 200 | 0.095 | |
| neutrophil mediated immunity | GO:0002446 | 19 | 0.087 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.087 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.084 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.084 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.081 | |
| skeletal system development | GO:0001501 | 356 | 0.081 | |
| muscle tissue development | GO:0060537 | 308 | 0.075 | |
| amine metabolic process | GO:0009308 | 45 | 0.074 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.073 | |
| striated muscle contraction | GO:0006941 | 45 | 0.073 | |
| cytokine production | GO:0001816 | 319 | 0.069 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.069 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.067 | |
| mapk cascade | GO:0000165 | 281 | 0.066 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.065 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.064 | |
| muscle system process | GO:0003012 | 141 | 0.063 | |
| disruption of cells of other organism involved in symbiotic interaction | GO:0051818 | 13 | 0.063 | |
| regulation of protein localization | GO:0032880 | 231 | 0.062 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.061 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.060 | |
| disruption of cells of other organism | GO:0044364 | 13 | 0.060 | |
| defense response to bacterium | GO:0042742 | 119 | 0.058 | |
| blood circulation | GO:0008015 | 195 | 0.058 | |
| glucose homeostasis | GO:0042593 | 128 | 0.057 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.055 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.054 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.053 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.053 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.053 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.052 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.052 | |
| immune effector process | GO:0002252 | 321 | 0.052 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.052 | |
| circulatory system process | GO:0003013 | 197 | 0.052 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.052 | |
| cell adhesion | GO:0007155 | 329 | 0.052 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.051 | |
| regulation of cell motility | GO:2000145 | 236 | 0.051 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.050 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.050 | |
| regulation of secretion | GO:0051046 | 274 | 0.050 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.050 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.050 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.050 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.049 | |
| sperm motility | GO:0030317 | 47 | 0.049 | |
| action potential | GO:0001508 | 78 | 0.048 | |
| inflammatory response | GO:0006954 | 244 | 0.047 | |
| membrane organization | GO:0061024 | 245 | 0.047 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.047 | |
| blastocyst development | GO:0001824 | 80 | 0.046 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.046 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.046 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.046 | |
| protein maturation | GO:0051604 | 176 | 0.044 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.043 | |
| defense response to other organism | GO:0098542 | 197 | 0.043 | |
| defense response to fungus | GO:0050832 | 12 | 0.042 | |
| killing by host of symbiont cells | GO:0051873 | 11 | 0.042 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.041 | |
| gland development | GO:0048732 | 330 | 0.041 | |
| extracellular structure organization | GO:0043062 | 148 | 0.039 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.039 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.039 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.038 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.038 | |
| response to oxygen levels | GO:0070482 | 62 | 0.038 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.037 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.037 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.037 | |
| ossification | GO:0001503 | 216 | 0.037 | |
| fertilization | GO:0009566 | 127 | 0.036 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.035 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.035 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.035 | |
| killing of cells in other organism involved in symbiotic interaction | GO:0051883 | 13 | 0.035 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.034 | |
| response to steroid hormone | GO:0048545 | 56 | 0.034 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.034 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.034 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.033 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.033 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.033 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.033 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.032 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.032 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.032 | |
| disruption by host of symbiont cells | GO:0051852 | 11 | 0.032 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.032 | |
| t cell proliferation | GO:0042098 | 120 | 0.032 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.032 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.032 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.032 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.032 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.032 | |
| single fertilization | GO:0007338 | 82 | 0.031 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.030 | |
| axonogenesis | GO:0007409 | 274 | 0.030 | |
| modification by host of symbiont morphology or physiology | GO:0051851 | 12 | 0.030 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.030 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.030 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.030 | |
| cardiac chamber development | GO:0003205 | 108 | 0.030 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.029 | |
| cellular homeostasis | GO:0019725 | 240 | 0.029 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.029 | |
| connective tissue development | GO:0061448 | 179 | 0.029 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.029 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.029 | |
| regulation of defense response | GO:0031347 | 233 | 0.029 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.029 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.029 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.029 | |
| developmental cell growth | GO:0048588 | 84 | 0.029 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.028 | |
| angiogenesis | GO:0001525 | 201 | 0.028 | |
| protein localization to membrane | GO:0072657 | 108 | 0.028 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.028 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.028 | |
| cell maturation | GO:0048469 | 127 | 0.028 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.028 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.028 | |
| regulation of serotonin secretion | GO:0014062 | 3 | 0.028 | |
| limb development | GO:0060173 | 166 | 0.027 | |
| organ growth | GO:0035265 | 117 | 0.027 | |
| response to nutrient levels | GO:0031667 | 109 | 0.027 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.027 | |
| killing of cells of other organism | GO:0031640 | 13 | 0.027 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.027 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.027 | |
| regulation of ossification | GO:0030278 | 112 | 0.027 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.027 | |
| regulation of protein transport | GO:0051223 | 163 | 0.027 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.027 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.026 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.026 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.026 | |
| protein processing | GO:0016485 | 163 | 0.026 | |
| cation homeostasis | GO:0055080 | 212 | 0.026 | |
| camera type eye development | GO:0043010 | 266 | 0.026 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.026 | |
| cell recognition | GO:0008037 | 83 | 0.025 | |
| adaptive immune response | GO:0002250 | 155 | 0.025 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.025 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.025 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.025 | |
| positive regulation of muscle adaptation | GO:0014744 | 2 | 0.025 | |
| tube closure | GO:0060606 | 91 | 0.025 | |
| forebrain development | GO:0030900 | 302 | 0.025 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.025 | |
| cation transport | GO:0006812 | 399 | 0.025 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.025 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.025 | |
| regulation of tube size | GO:0035150 | 57 | 0.025 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.025 | |
| cell cell adhesion | GO:0098609 | 41 | 0.025 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.025 | |
| cell killing | GO:0001906 | 67 | 0.024 | |
| appendage development | GO:0048736 | 166 | 0.024 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.024 | |
| interaction with symbiont | GO:0051702 | 14 | 0.024 | |
| neutrophil mediated killing of symbiont cell | GO:0070943 | 8 | 0.024 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.024 | |
| primary neural tube formation | GO:0014020 | 95 | 0.024 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 16 | 0.024 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.024 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.023 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.023 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.023 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.023 | |
| endocytosis | GO:0006897 | 168 | 0.023 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.023 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.023 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.023 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.023 | |
| transmembrane transport | GO:0055085 | 412 | 0.022 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.022 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.022 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.022 | |
| germ cell development | GO:0007281 | 185 | 0.022 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.022 | |
| response to growth factor | GO:0070848 | 198 | 0.022 | |
| endocrine process | GO:0050886 | 39 | 0.022 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.021 | |
| hindbrain development | GO:0030902 | 128 | 0.021 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.021 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.021 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.021 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.021 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.020 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.020 | |
| metanephric ascending thin limb development | GO:0072218 | 2 | 0.020 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.020 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.020 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.020 | |
| epithelium migration | GO:0090132 | 63 | 0.020 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.020 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.020 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.020 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.020 | |
| positive regulation of growth | GO:0045927 | 104 | 0.020 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.020 | |
| regulation of organ growth | GO:0046620 | 61 | 0.020 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.020 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.020 | |
| cartilage development | GO:0051216 | 140 | 0.020 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.020 | |
| locomotory behavior | GO:0007626 | 195 | 0.020 | |
| phagocytosis | GO:0006909 | 66 | 0.019 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.019 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.019 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.019 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.019 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.019 | |
| response to inorganic substance | GO:0010035 | 96 | 0.019 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.019 | |
| growth involved in symbiotic interaction | GO:0044110 | 23 | 0.019 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.019 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.019 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.019 | |
| regulation of cell migration | GO:0030334 | 219 | 0.018 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.018 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.018 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.018 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.018 | |
| exocytosis | GO:0006887 | 121 | 0.018 | |
| male gamete generation | GO:0048232 | 285 | 0.018 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.018 | |
| lipid localization | GO:0010876 | 126 | 0.018 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.018 | |
| response to starvation | GO:0042594 | 65 | 0.018 | |
| muscle cell development | GO:0055001 | 133 | 0.018 | |
| ectoderm formation | GO:0001705 | 3 | 0.018 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.018 | |
| regulation of ion transport | GO:0043269 | 215 | 0.017 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.017 | |
| response to oxidative stress | GO:0006979 | 123 | 0.017 | |
| fat cell differentiation | GO:0045444 | 160 | 0.017 | |
| regulation of brown fat cell proliferation | GO:0070347 | 1 | 0.017 | |
| sensory perception | GO:0007600 | 245 | 0.017 | |
| cell junction organization | GO:0034330 | 77 | 0.017 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.017 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.017 | |
| myotube differentiation | GO:0014902 | 105 | 0.017 | |
| neural crest cell migration | GO:0001755 | 32 | 0.017 | |
| ear morphogenesis | GO:0042471 | 118 | 0.017 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.017 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.017 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 4 | 0.017 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.017 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.016 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.016 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.016 | |
| lipid homeostasis | GO:0055088 | 63 | 0.016 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.016 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.016 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.016 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.016 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.016 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.016 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.015 | |
| chemotaxis | GO:0006935 | 247 | 0.015 | |
| steroid metabolic process | GO:0008202 | 119 | 0.015 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.015 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.015 | |
| regulation of protein processing | GO:0070613 | 96 | 0.015 | |
| male sex differentiation | GO:0046661 | 109 | 0.015 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.015 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.015 | |
| cytokine secretion | GO:0050663 | 72 | 0.015 | |
| anion transport | GO:0006820 | 177 | 0.015 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.015 | |
| plasma membrane organization | GO:0007009 | 90 | 0.015 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.015 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.015 | |
| heart morphogenesis | GO:0003007 | 178 | 0.015 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.015 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.015 | |
| negative regulation of growth | GO:0045926 | 99 | 0.015 | |
| neuron death | GO:0070997 | 154 | 0.015 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.014 | |
| muscle fiber development | GO:0048747 | 76 | 0.014 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.014 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.014 | |
| limb morphogenesis | GO:0035108 | 149 | 0.014 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.014 | |
| growth of symbiont involved in interaction with host | GO:0044116 | 23 | 0.014 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.014 | |
| neutrophil mediated cytotoxicity | GO:0070942 | 8 | 0.014 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.014 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.014 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.014 | |
| digestive tract development | GO:0048565 | 190 | 0.014 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.014 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.014 | |
| cell growth | GO:0016049 | 130 | 0.014 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.014 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.014 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.014 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.014 | |
| glucose metabolic process | GO:0006006 | 92 | 0.014 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.013 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.013 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.013 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.013 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.013 | |
| response to radiation | GO:0009314 | 165 | 0.013 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.013 | |
| synaptic transmission | GO:0007268 | 329 | 0.013 | |
| neuron projection guidance | GO:0097485 | 141 | 0.013 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.013 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.013 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.013 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.013 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.013 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.013 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.013 | |
| binding of sperm to zona pellucida | GO:0007339 | 34 | 0.013 | |
| b cell activation | GO:0042113 | 161 | 0.013 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.013 | |
| cognition | GO:0050890 | 149 | 0.013 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.013 | |
| neuromuscular process | GO:0050905 | 99 | 0.013 | |
| heart process | GO:0003015 | 94 | 0.013 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.013 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.013 | |
| negative regulation of neuron projection regeneration | GO:0070571 | 3 | 0.013 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.013 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.013 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.013 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.013 | |
| activation of immune response | GO:0002253 | 138 | 0.013 | |
| biomineral tissue development | GO:0031214 | 64 | 0.013 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.012 | |
| peptide metabolic process | GO:0006518 | 46 | 0.012 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.012 | |
| positive regulation of skeletal muscle fiber development | GO:0048743 | 3 | 0.012 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.012 | |
| gonad morphogenesis | GO:0035262 | 1 | 0.012 | |
| multicellular organism growth | GO:0035264 | 161 | 0.012 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.012 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.012 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.012 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.012 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.012 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.012 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.012 | |
| protein oligomerization | GO:0051259 | 67 | 0.012 | |
| stem cell maintenance | GO:0019827 | 130 | 0.012 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.012 | |
| glucose transport | GO:0015758 | 56 | 0.012 | |
| regulation of cell activation | GO:0050865 | 289 | 0.012 | |
| response to monosaccharide | GO:0034284 | 67 | 0.012 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.012 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.012 | |
| positive regulation of b cell mediated immunity | GO:0002714 | 26 | 0.012 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.012 | |
| tissue migration | GO:0090130 | 68 | 0.012 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.012 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.012 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.012 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.012 | |
| heart growth | GO:0060419 | 45 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.012 | |
| bone development | GO:0060348 | 120 | 0.012 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.012 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.012 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.012 | |
| endothelial cell migration | GO:0043542 | 44 | 0.011 | |
| heart contraction | GO:0060047 | 93 | 0.011 | |
| stem cell proliferation | GO:0072089 | 117 | 0.011 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.011 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.011 | |
| hormone metabolic process | GO:0042445 | 86 | 0.011 | |
| myotube cell development | GO:0014904 | 60 | 0.011 | |
| hormone secretion | GO:0046879 | 128 | 0.011 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.011 | |
| protein catabolic process | GO:0030163 | 221 | 0.011 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.011 | |
| tube formation | GO:0035148 | 140 | 0.011 | |
| cell cell junction organization | GO:0045216 | 72 | 0.011 | |
| regulation of heart growth | GO:0060420 | 31 | 0.011 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.011 | |
| cellular response to starvation | GO:0009267 | 57 | 0.011 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.011 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.011 | |
| positive regulation of calcium mediated signaling | GO:0050850 | 15 | 0.011 | |
| rna processing | GO:0006396 | 105 | 0.011 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.011 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.011 | |
| actin filament organization | GO:0007015 | 113 | 0.011 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.011 | |
| sensory system development | GO:0048880 | 3 | 0.011 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.011 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.011 | |
| palate development | GO:0060021 | 76 | 0.011 | |
| amide transport | GO:0042886 | 138 | 0.011 | |
| inner ear receptor cell development | GO:0060119 | 39 | 0.011 | |
| axon ensheathment | GO:0008366 | 76 | 0.011 | |
| regulation of inositol trisphosphate biosynthetic process | GO:0032960 | 3 | 0.011 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.011 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.011 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.011 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.011 | |
| response to acid chemical | GO:0001101 | 111 | 0.010 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.010 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.010 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.010 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.010 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.010 | |
| neural tube closure | GO:0001843 | 90 | 0.010 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.010 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.010 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.010 | |
| compound eye development | GO:0048749 | 1 | 0.010 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.010 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.010 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.010 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.010 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.010 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.010 | |
| cellular response to lipid | GO:0071396 | 145 | 0.010 | |
| visual perception | GO:0007601 | 52 | 0.010 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.010 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.010 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.010 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.010 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.010 | |
| stem cell development | GO:0048864 | 219 | 0.010 | |
| pharynx development | GO:0060465 | 1 | 0.010 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.010 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.010 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.010 | |
| neural tube formation | GO:0001841 | 108 | 0.010 | |
| modification of morphology or physiology of other organism | GO:0035821 | 18 | 0.010 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.010 | |
